Celiac Disease:A Multisystem Autoimmune Disorder

Gastroenterology Nursing

Volumn 28, Issue 5, 2005, Pages 394-402

  Meize Grochowski, Robin ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTEN;

AUTOIMMUNE DISEASE; CELIAC DISEASE; COMPARATIVE STUDY; DIET; DIET THERAPY; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOLOGY; MALE; NURSE ATTITUDE; NURSING; NURSING RESEARCH; ORGANIZATION AND MANAGEMENT; PREVALENCE; PROGNOSIS; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME;

AUTOIMMUNE DISEASES; CELIAC DISEASE; DIET; FEMALE; GLUTEN; HUMANS; MALE; NURSE'S ROLE; NURSING RESEARCH; NURSING, TEAM; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33644823076     PISSN: 1042895X     EISSN: 15389766     Source Type: Journal    
DOI: 10.1097/00001610-200509000-00005     Document Type: Article

References (49)

1. Agency for Healthcare Research and Quality. (2004). Celiac disease: Summary. Evidence Report/Technology Assessment, No. 104, 1-6 (AHRQ Pub. No. 04-E029-1, June 2004). Washington, DC: Author.
2. Alaedini, A., & Green, P. H. R. (2005). Narrative review: Celiac disease: Understanding a complex autoimmune disorder. Annals of Internal Medicine, 142, 289-298.
3. American Gastroenterological Association. (2001). American Gastroenterological Association medical position statement: Celiac sprue. Gastroenterology, 120, 1522-1525.
4. Biagi, F., Campanella, J., Martucci, S., Pezzimenti, D., Ciclitira, P. J., Ellis, H. J., et al. (2004). A milligram of gluten a day keeps the mucosal recovery away: A case report. Nutrition Reviews, 62, 360-363.
5. Biagi, F., & Corazza, G. R. (2001). Defining gluten refractory enteropathy. European Journal of Gastroenterology and Hepatology, 13, 561-565.
6. Ciacci, C., Cavallaro, R., Valle, N., & d'Argenio, G. (2002). The use of serum tTG-ab assay in patients on gluten-free diet as a measure of dietetic compliance. Gastroenterology, 122, 588-595.
7. Ciacci, C., Iavarone, A., Mazzacca, G., & De Rosa, A. (1998). Depressive symptoms in adult coeliac disease. Scandinavian Journal of Gastroenterology, 33, 247-250.
8. Ciclitira, P. J. (2001) AGA technical review on celiac sprue. Gastroenterology, 120, 1526-1540.
9. Clemente, M. G., De Virgiliis, S., Kang, J. S., Macatagney, R., Musu, M. P., Di Pierro, M. R., et al. (2003). Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut, 52, 218-223.
10. Collin, P., Kaukinen, K., Vogelsang, H., Korponay-Szabó, I., Sommer, R., Schreier, E., et al. (2005). Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: A biopsy-proven European multicentre study. European Journal of Gastroenterology and Hepatology, 17, 85-91.
11. Corrao, G., Corazza, G. R., Bagnardi, V., Brusco, G., Ciacci, C., Cottone, M., et al. (2001). Mortality in patients with coeliac disease and their relatives: A cohort study. The Lancet, 358, 356-361.
12. Dennis, M., & Case, S. (2004). Going gluten-free: A primer for clinicians. Practical Gastroenterology, 28, 86, 88-90, 92-94, 96-98, 100-102, 104.
13. Dickey, W., & McConnell, J. B. (1996). How many hospital visits does it take before celiac sprue is diagnosed? Journal of Clinical Gastroenterology, 23, 21-23.
14. Dieterich, W., Ehnis, T., Bauer, M., Donner, P., Volta, U., Riecken, E. O., et al. (1997). Identification of tissue transglutaminase as the autoantigen of celiac disease. Nature Medicine, 3, 797-801.
15. Drago, S., Di Pierro, M., Catassi, C., & Fasano, A. (2002). Recent developments in the pathogenesis, diagnosis and treatment of celiac disease. Expert Opinion on Therapeutic Patents, 12, 45-51.
16. Farrell, R. J., & Kelly, C. P. (2002). Current concepts: Celiac sprue. The New England Journal of Medicine, 346, 180-188.
17. Fasano, A. (2001). Intestinal zonulin: Open sesame! Gut, 49, 159-162.
18. Fasano, A., Berti, I., Gerarduzzi, T., Not, T., Colletti, R. B., Drago, S., et al. (2003). Prevalence of celiac disease in at-risk and not-at-risk groups in the United States. Archives of Internal Medicine, 163, 286-292.
19. Fasano, A., & Catassi, C. (2001). Current approaches to diagnosis and treatment of celiac disease: An evolving spectrum. Gastroenterology, 120, 636-651.
20. Fasano, A., Not, T., Wang, W., Uzzau, S., Berti, I., Tommasini, A., et al. (2000). Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. The Lancet, 355, 1518-1519.
21. George, E. K., Mearin, M. L., Bouquet, J., von Blomberg, B. M. E., Stapel, S. O., van Elburg, R. M., et al. (1996). High frequency of celiac disease in Down syndrome. The Journal of Pediatrics, 128, 555-557.
22. Green, P. H. R., & Jabri, B. (2003). Coeliac disease. The Lancet, 362, 383-391.
23. Green, P. H. R., Stavropoulos, S. N., Panagi, S. G., Goldstein, S. L., McMahon, D. J., Absan, H., et al. (2001). Characteristics of adult celiac disease in the USA: Results of a national survey. The American Journal of Gastroenterology, 96, 126-131.
24. Griffin, M., Casadio, R., & Bergamini, C. M. (2002). Transglutaminases: Nature's biological glues. Biochemical Journal, 368, 377-396.
25. Hill, I. D. (2003). Celiac disease—a never-ending story? The Journal of Pediatrics, 43, 289-291.
26. Hill, I. D., Dirks, M. H., Liptak, G. S., Colletti, R. B., Fasano, A., Guandalini, S., et al. (2005). Guideline for the diagnosis and treatment of celiac disease in children: Recommendation of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Journal of Pediatric Gastroenterology and Nutrition, 40, 1-19.
27. Hoffenberg, E. J., MacKenzie, T., Barriga, K. J., Eisenbarth, G. S., Bao, F., Haas, J. E., et al. (2003). A prospective study of the incidence of childhood celiac disease. Journal of Pediatrics, 143, 308-314.
28. Huff, C. (1997). Celiac disease: Helping families adapt. Gastroenterology Nursing, 20, 79-81.
29. Mäki, M., Mustalahti, K., Kokkonen, J., Kulmala, P., Haapalahti, M., Karttunen, T., et al. (2003). Prevalence of celiac disease among children in Finland. The New England Journal of Medicine, 348, 2517-2524.
30. Marinaro, M., Fasano, A., & De Magistris, M. T. (2003). Zonula occludens toxin acts as an adjuvant through different mucosal routes and induces protective immune responses. Infection and Immunity, 71, 1897-1902.
31. Marsh, M. N., (1992). Gluten, major histocompatibility complex, and the small intestine. Gastroenterology, 102, 330-354.
32. McManus, R., & Kelleher, D. (2003). Celiac disease—the villain unmasked? The New England Journal of Medicine, 348, 2573-2574.
33. Murdock, A. M., & Johnston, S. D. (2005). Diagnostic criteria for coeliac disease: Time for change? European Journal of Gastroenterology & Hepatology, 17, 41-43.
34. National Institutes of Health. (2004). Final statement. NIH Consensus Development Conference—Celiac Disease, June 28-30, 2004.
35. Nelsen, D. A. (2002). Gluten-sensitive enteropathy (celiac disease): More common than you think. American Family Physician, 66, 2259-2266.
36. Ravelli, A., Bolognini, S., Gambarotti, M., & Villanacci, V. (2005). Variability of histologic lesions in relation to biopsy site in gluten-sensitive enteropathy. The American Journal of Gastroenterology, 100, 177-185.
37. Schulzke, J. D., Bentzel, C. J., Schulzke, I., Riecken, E. O., & Fromm, M. (1998). Epithelial tight junction structure in the jejunum of children with acute and treated celiac sprue. Pediatric Research, 43, 435-441.
38. Schuppan, D. (2000). Current concepts of celiac disease pathogenesis. Gastroenterology, 119, 234-242.
39. Schuppan, D., & Hahn, E. G. (2002). Gluten and the gut—lessons for immune regulation. Science, 297, 2218-2220.
40. Smedby, K. E., Åkerman, M., Hildebrand, H., Glimelius, B., Ekbom, A., & Askling, J. (2005). Malignant lymphomas in coeliac disease: Evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut, 54, 54-59.
41. Stenson, W. F., Newberry, R., Lorenz, R., Baldus, C., & Civitelli, R. (2005). Increased prevalence of celiac disease and need for routine screening among persons with osteoporosis. Archives of Internal Medicine, 165, 393-399.
42. Talley, N. J., Valdovinos, M., Petterson, T. M., Carpenter, H. A., & Melton, J. (1994). Epidemiology of celiac sprue: A community-based study. American Journal of Gastroenterology, 89, 843-846.
43. Thijs, W. J., van Baarlen, J., Kleibeuker, J. H., & Kolkman, J. J. (2004). Duodenal versus jejunal biopsies in suspected celiac disease. Endoscopy, 36, 993-996.
44. Vahedi, K., Mascart, F., Mary, J. Y., Laberenne, J. E., Bouhnik, Y., Morin, M. C., et al. (2003). Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. American Journal of Gastroenterology, 98, 1079-1087.
45. Ventura, A., Magazzu, G., & Greco, L. (1999). Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology, 117, 297-303.
46. Wahab, P. J., Meijer, J. W. R., & Mulder, C. J. J. (2002). Histologic follow up of people with celiac disease on a gluten-free diet: Slow and incomplete recovery. American Journal of Clinical Pathology, 118, 459-463.
47. Walker-Smith, J. A., Guandalini, S., Schmitz, J., Shmerling, D. H., & Visakorpi, J. K. (1990). Revised criteria for diagnosis of coeliac disease. Archives of Disease in Childhood, 65, 909-911.
48. West, J., Logan, R. F. A., Smith, C. J., Hubbard, R. B., & Card, T. R. (2004). Malignancy and mortality in people with coeliac disease: Population based cohort study. British Medical Journal, 329, 716-719.
49. Zelnik, N., Pacht, A., Obeid, R., & Lerner, A. (2004). Range of neurologic disorders in patients with celiac disease. Pediatrics, 113, 1672-1676.